Linda Stein Gold

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

Amy S. Paller, Wynnis L. Tom, Mark Lebwohl et al. · Journal of the American Academy of Dermatology · 2016 · 565 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

Jonathan I. Silverberg, Emma Guttman‐Yassky, Diamant Thaçi et al. · New England Journal of Medicine · 2023 · 314 citations

Medicine, Dermatology, Pharmacology +17

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

Eric L. Simpson, Kim Papp, Andrew Blauvelt et al. · JAMA Dermatology · 2022 · 204 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

Mark Lebwohl, Linda Stein Gold, Bruce Strober et al. · New England Journal of Medicine · 2021 · 178 citations

Medicine, Dermatology, Pharmacotherapy +16

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

Lawrence F. Eichenfield, Robert S. Call, Douglass W. Forsha et al. · Journal of the American Academy of Dermatology · 2017 · 149 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15